Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George A Pankey

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Antimicrobial Chemotherapy|July 26, 2005
TigecyclineGeorge A Pankey
Ochsner Journal|July 25, 2012
A report on vaccine availability and administration protocols as of august 2002Hugh Durham, George A Pankey
Antimicrobial Agents and Chemotherapy|June 28, 2005
In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosaGeorge A Pankey, Deborah S Ashcraft
Microbiology Spectrum|January 14, 2017
Tuberculous OtomastoiditisJonathan M Hand, George A Pankey
Diagnostic Microbiology and Infectious Disease|July 20, 2011
Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniaeGeorge A Pankey, Deborah S Ashcraft
Critical Care Clinics|March 26, 2008
Tigecycline in critical carePraveen K Mullangi, George A Pankey
Ochsner Journal|March 28, 2013
In Vitro Synergy of Telavancin and Rifampin Against Enterococcus faecium Resistant to Both Linezolid and VancomycinGeorge A Pankey, Deborah S Ashcraft
Diagnostic Microbiology and Infectious Disease|January 20, 2009
The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assayGeorge A Pankey, Deborah S Ashcraft
Therapeutics and Clinical Risk Management|May 1, 2015
Update on the emerging role of telavancin in hospital-acquired infectionsObinna N Nnedu, George A Pankey
Diagnostic Microbiology and Infectious Disease|June 9, 2009
In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assayGeorge A Pankey, Deborah S Ashcraft
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|July 26, 2005
TigecyclineGeorge A Pankey
Ochsner Journal|July 25, 2012
A report on vaccine availability and administration protocols as of august 2002Hugh Durham, George A Pankey
Antimicrobial Agents and Chemotherapy|June 28, 2005
In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosaGeorge A Pankey, Deborah S Ashcraft
Microbiology Spectrum|January 14, 2017
Tuberculous OtomastoiditisJonathan M Hand, George A Pankey
Diagnostic Microbiology and Infectious Disease|July 20, 2011
Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniaeGeorge A Pankey, Deborah S Ashcraft
Critical Care Clinics|March 26, 2008
Tigecycline in critical carePraveen K Mullangi, George A Pankey
Ochsner Journal|March 28, 2013
In Vitro Synergy of Telavancin and Rifampin Against Enterococcus faecium Resistant to Both Linezolid and VancomycinGeorge A Pankey, Deborah S Ashcraft
Diagnostic Microbiology and Infectious Disease|January 20, 2009
The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assayGeorge A Pankey, Deborah S Ashcraft
Therapeutics and Clinical Risk Management|May 1, 2015
Update on the emerging role of telavancin in hospital-acquired infectionsObinna N Nnedu, George A Pankey
Diagnostic Microbiology and Infectious Disease|June 9, 2009
In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assayGeorge A Pankey, Deborah S Ashcraft
Pageof 3